|
US4525350A
(en)
|
1975-02-20 |
1985-06-25 |
The New England Institute, Inc. |
Methods of stimulating host defense system with coenzymes Q4 to Q.sub.1
|
|
JPS5775916A
(en)
|
1980-10-29 |
1982-05-12 |
Nippon Chemiphar Co Ltd |
Coenzyme q pharmaceutical and its preparation
|
|
JPS58113127A
(ja)
|
1981-12-28 |
1983-07-05 |
Ajinomoto Co Inc |
ユビデカレノン含有水性液
|
|
IT1157269B
(it)
|
1982-03-19 |
1987-02-11 |
Seuref Ag |
Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
|
|
JPS58201711A
(ja)
|
1982-05-19 |
1983-11-24 |
Eisai Co Ltd |
ユビデカレノン含有リポソ−ム被覆体
|
|
US4515736A
(en)
*
|
1983-05-12 |
1985-05-07 |
The Regents Of The University Of California |
Method for encapsulating materials into liposomes
|
|
US4833128A
(en)
|
1984-12-28 |
1989-05-23 |
Neil Solomon |
Dietary supplement
|
|
US4824669A
(en)
|
1985-04-11 |
1989-04-25 |
Board Of Regents, The University Of Texas System |
Formulations of coenzyme Q10 for intravenous use
|
|
US4895727A
(en)
*
|
1985-05-03 |
1990-01-23 |
Chemex Pharmaceuticals, Inc. |
Pharmaceutical vehicles for exhancing penetration and retention in the skin
|
|
JPS62123113A
(ja)
|
1985-11-22 |
1987-06-04 |
Green Cross Corp:The |
ユビデカレノン含有脂肪乳剤
|
|
US4843071A
(en)
|
1986-12-05 |
1989-06-27 |
Serotonin Industries Of Charleston |
Method and composition for treating obesity, drug abuse, and narcolepsy
|
|
US5651991A
(en)
|
1987-10-28 |
1997-07-29 |
Nippon Shinyaku Co. Ltd. |
Drug carriers
|
|
JP2600726B2
(ja)
|
1987-11-30 |
1997-04-16 |
大正製薬株式会社 |
微粒子脂肪乳剤
|
|
GB8811410D0
(en)
|
1988-05-13 |
1988-06-15 |
Unilever Plc |
Treatment of skin disorders
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5015483A
(en)
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
|
JP2828655B2
(ja)
|
1989-04-14 |
1998-11-25 |
エーザイ株式会社 |
脂溶性薬物含有水性液
|
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US5962243A
(en)
|
1990-04-18 |
1999-10-05 |
Board Of Regents, The University Of Texas System |
Methods for the identification of farnesyltransferase inhibitors
|
|
DE69107056T4
(de)
|
1990-11-14 |
1996-06-13 |
L'oreal, Paris |
Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
|
|
SE502569C2
(sv)
*
|
1991-05-31 |
1995-11-13 |
British Tech Group |
Användning av en immunologiskt inert matris av en sterol och saponiner som kan bilda sfäriska nanopartiklar med snäv storleksfördelning som läkemedelsbärare, partiklar, komposition samt kit
|
|
US5378461A
(en)
|
1991-07-12 |
1995-01-03 |
Neigut; Stanley J. |
Composition for the topical treatment of skin damage
|
|
US5605930A
(en)
|
1991-10-21 |
1997-02-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Compositions and methods for treating and preventing pathologies including cancer
|
|
US6461593B1
(en)
|
1992-02-19 |
2002-10-08 |
Biomedical And Clinical Research |
Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
|
|
JPH07504198A
(ja)
|
1992-02-24 |
1995-05-11 |
イースト カロライナ ユニバーシティ |
デヒドロエピアンドロステロンおよびその類縁体を用いる処置によって発癌を抑制する方法
|
|
US6093706A
(en)
|
1992-03-04 |
2000-07-25 |
Bioresponse, L.L.C. |
Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
|
|
FR2697841B1
(fr)
|
1992-11-12 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5602184A
(en)
*
|
1993-03-03 |
1997-02-11 |
The United States Of America As Represented By Department Of Health And Human Services |
Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
|
|
US5719303A
(en)
|
1993-03-08 |
1998-02-17 |
Eisai Co., Ltd. |
Phosphonic acid derivatives
|
|
ATE166573T1
(de)
|
1993-03-24 |
1998-06-15 |
Ciba Geigy Ag |
Verfahren zur herstellung einer liposomendispersion im hochdruckbereich
|
|
DE4327063A1
(de)
|
1993-08-12 |
1995-02-16 |
Kirsten Dr Westesen |
Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
DE4410238A1
(de)
|
1994-03-25 |
1995-09-28 |
Beiersdorf Ag |
Hautpflegemittel
|
|
US20020049422A1
(en)
*
|
1994-03-31 |
2002-04-25 |
Brewitt Barbara A. |
Homeopathic preparations
|
|
AU4510596A
(en)
|
1994-12-06 |
1996-06-26 |
National Research Council Of Canada |
Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
|
|
US6958150B2
(en)
|
1994-12-15 |
2005-10-25 |
Advance Biofactures Of Curacao, N.V. |
Reduction of adipose tissue
|
|
US6005086A
(en)
|
1995-01-13 |
1999-12-21 |
The Salk Institute For Biological Studies |
Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
|
|
DE19537027A1
(de)
|
1995-10-05 |
1997-04-10 |
Beiersdorf Ag |
Hautpflegemittel für alte Haut
|
|
EP0856026A1
(en)
|
1995-10-19 |
1998-08-05 |
Receptagen Corporation |
Discrete-length polyethylene glycols
|
|
US5944012A
(en)
|
1996-03-25 |
1999-08-31 |
Pera; Ivo E. |
Method for dispensing antioxidant vitamins by inhalation background of the invention
|
|
DE19615577A1
(de)
*
|
1996-04-19 |
1997-10-23 |
Beiersdorf Ag |
Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
|
|
US5891465A
(en)
*
|
1996-05-14 |
1999-04-06 |
Biozone Laboratories, Inc. |
Delivery of biologically active material in a liposomal formulation for administration into the mouth
|
|
GB9625895D0
(en)
|
1996-12-13 |
1997-01-29 |
Riley Patrick A |
Novel compound useful as therapeutic agents and assay reagents
|
|
EP1007021B1
(de)
|
1997-02-11 |
2001-06-13 |
MSE Pharmazeutika GmbH |
Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
|
|
US20040228910A1
(en)
|
1997-02-11 |
2004-11-18 |
Mse Pharmazeutika Gmbh |
Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
|
|
WO1998035658A2
(de)
*
|
1997-02-12 |
1998-08-20 |
Mse Pharmazeutika Gmbh |
Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
|
|
IT1291113B1
(it)
*
|
1997-03-20 |
1998-12-29 |
Sigma Tau Ind Farmaceuti |
Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
|
|
US6599513B2
(en)
|
1997-05-27 |
2003-07-29 |
Sembiosys Genetics Inc. |
Products for topical applications comprising oil bodies
|
|
US6372234B1
(en)
|
1997-05-27 |
2002-04-16 |
Sembiosys Genetics Inc. |
Products for topical applications comprising oil bodies
|
|
CA2303200A1
(en)
|
1997-09-04 |
1999-03-11 |
Brian C. Keller |
Oral liposomal delivery system
|
|
EP1027045A4
(en)
|
1997-10-31 |
2004-12-08 |
Arch Dev Corp |
METHODS AND COMPILATIONS FOR REGULATING S-ALPHA REDUCTASE ACTIVITY
|
|
US6696484B2
(en)
*
|
1997-10-31 |
2004-02-24 |
University Of Chicago Office Of Technology And Intellectual Property |
Method and compositions for regulation of 5-alpha reductase activity
|
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
US6372880B1
(en)
*
|
1997-12-25 |
2002-04-16 |
Mitsui Chemicals, Inc. |
Copolymer and process for preparing the same
|
|
US6048846A
(en)
|
1998-02-26 |
2000-04-11 |
Cochran; Timothy M. |
Compositions used in human treatment
|
|
WO1999051097A1
(en)
|
1998-04-02 |
1999-10-14 |
Avicena Group, Inc. |
Compositions containing a combination of a creatine compound and a second agent
|
|
AU3169999A
(en)
|
1998-04-14 |
1999-11-01 |
Kyowa Hakko Kogyo Co. Ltd. |
Process for producing isoprenoid compounds by using microorganisms and method for detecting compounds having antibacterial or herbicidal activity
|
|
US6503523B2
(en)
*
|
1998-05-07 |
2003-01-07 |
Gs Development A.B. |
Skin care agents containing combinations of active agents consisting of vitamin a derivatives and UBI- or plastoquinones
|
|
ES2194477T3
(es)
|
1998-06-19 |
2003-11-16 |
Skyepharma Canada Inc |
Procedimiento para generar particulas de compuestos insolubles en agua con un tamaño de hasta 2000 nm.
|
|
US6093743A
(en)
|
1998-06-23 |
2000-07-25 |
Medinox Inc. |
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
|
|
DE19828081C2
(de)
|
1998-06-24 |
2000-08-10 |
Cognis Deutschland Gmbh |
W/O-Emulsionsgrundlagen
|
|
EP1097270B1
(de)
|
1998-07-16 |
2003-06-04 |
Cognis Deutschland GmbH & Co. KG |
Verwendung von pit-emulsionen
|
|
AU750313B2
(en)
|
1998-07-27 |
2002-07-18 |
St. Jude Pharmaceuticals, Inc. |
Chemically induced intracellular hyperthermia
|
|
AU5334899A
(en)
|
1998-08-04 |
2000-02-28 |
Kosbab, John V. |
Nutrient and therapeutic compositions for the treatment of cancer
|
|
CN1318413C
(zh)
*
|
1998-09-23 |
2007-05-30 |
研究发展基金会 |
生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途
|
|
US6048886A
(en)
|
1998-10-05 |
2000-04-11 |
Neigut; Stanley |
Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
|
|
IT1304406B1
(it)
|
1998-10-21 |
2001-03-19 |
Danital Italia S R L |
Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
|
|
US20050123938A1
(en)
|
1999-01-06 |
2005-06-09 |
Chondrogene Limited |
Method for the detection of osteoarthritis related gene transcripts in blood
|
|
US20040034107A1
(en)
*
|
1999-02-11 |
2004-02-19 |
Mse Pharmazeutika Gmbh |
Ubiquinone Qn for the treatment of pain
|
|
US20050019268A1
(en)
|
1999-02-11 |
2005-01-27 |
Mse Pharmazeutika Gmbh |
Spray containing ubiquinone Qn
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US20030104048A1
(en)
|
1999-02-26 |
2003-06-05 |
Lipocine, Inc. |
Pharmaceutical dosage forms for highly hydrophilic materials
|
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US6140067A
(en)
*
|
1999-04-30 |
2000-10-31 |
Mitokor |
Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
|
|
US6482943B1
(en)
|
1999-04-30 |
2002-11-19 |
Slil Biomedical Corporation |
Quinones as disease therapies
|
|
US6803193B1
(en)
|
1999-06-23 |
2004-10-12 |
The Penn State Research Foundation |
Methods to identify modulators of the mevalonate pathway in sterol synthesis
|
|
US6242491B1
(en)
|
1999-06-25 |
2001-06-05 |
Rima Kaddurah-Daouk |
Use of creatine or creatine compounds for skin preservation
|
|
US6960439B2
(en)
*
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
|
DE59912559D1
(de)
*
|
1999-07-02 |
2005-10-20 |
Cognis Ip Man Gmbh |
Mikrokapseln - III
|
|
US20030104080A1
(en)
|
1999-09-07 |
2003-06-05 |
Singh Parashu Ram |
Topical urea composition
|
|
US6630160B1
(en)
|
1999-09-07 |
2003-10-07 |
Genetic Services Management, Inc. |
Process to modulate disease risk with doses of a nutraceutical
|
|
US7005274B1
(en)
|
1999-09-15 |
2006-02-28 |
Migenix Corp. |
Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
|
|
KR20020063877A
(ko)
|
1999-10-14 |
2002-08-05 |
니신 오일 밀스 가부시키가이샤 |
피부개선제, 피부노화 방지제, 미백제 및 피부외용제
|
|
US7309688B2
(en)
|
2000-10-27 |
2007-12-18 |
Johnson & Johnson Consumer Companies |
Topical anti-cancer compositions and methods of use thereof
|
|
US20020049176A1
(en)
*
|
1999-11-10 |
2002-04-25 |
Anderson Christen M. |
Modulation of mitochondrial mass and function for the treatment of diseases and for target and drug discovery
|
|
US20030180352A1
(en)
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7083780B2
(en)
|
1999-12-11 |
2006-08-01 |
Cognis Deutschland Gmbh & Co. Kg |
Cosmetic composition containing hydroxyethers
|
|
AU5440901A
(en)
*
|
1999-12-20 |
2001-07-03 |
Cognis France, S.A. |
Cosmetic and/or pharmaceutical preparations
|
|
AUPQ515000A0
(en)
|
2000-01-19 |
2000-02-10 |
Grigg, Geoffrey Walter |
Treatment of uv induced immunosuppression
|
|
KR100784752B1
(ko)
|
2000-02-04 |
2007-12-13 |
다케다 야쿠힌 고교 가부시키가이샤 |
안정한 에멀젼 조성물
|
|
GB2360706B
(en)
|
2000-02-09 |
2002-07-17 |
Paul A Sneed |
Treatment of fibromyalgia with ubiquinone 10 and succinic acid
|
|
US20020044913A1
(en)
*
|
2000-02-11 |
2002-04-18 |
Hamilton Nathan D. |
Cosmetics to support skin metabolism
|
|
FR2804864B1
(fr)
|
2000-02-11 |
2003-04-04 |
Serobiologiques Lab Sa |
Extraits de residus issus de la fabrication du vin et leur utilisation en cosmetique ou pharmacologie
|
|
DE10007322A1
(de)
*
|
2000-02-17 |
2001-08-23 |
Cognis Deutschland Gmbh |
Perlglanzmittel
|
|
EP1127567B1
(de)
*
|
2000-02-17 |
2010-09-01 |
Basf Se |
Wässrige Dispersion wasserunlöslicher organischer UV-Filtersubstanzen
|
|
FR2805464B1
(fr)
|
2000-02-25 |
2003-02-14 |
Serobiologiques Lab Sa |
Preparations cosmetiques contenant des extraits de la plante mourera fluviatilis
|
|
DE10009996B4
(de)
|
2000-03-02 |
2005-10-13 |
Cognis Ip Management Gmbh |
Feststoffgranulate mit monodisperser Korngrößenverteilung, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
US6664287B2
(en)
|
2000-03-15 |
2003-12-16 |
Bethesda Pharmaceuticals, Inc. |
Antioxidants
|
|
US6866864B2
(en)
|
2000-03-20 |
2005-03-15 |
Ahmed Mousa |
Compositions and methods of use in the treatment of angiogenesis and vascular-related disorders
|
|
PL363113A1
(en)
|
2000-03-27 |
2004-11-15 |
Schott Glas |
New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
|
|
US6447760B2
(en)
|
2000-05-08 |
2002-09-10 |
Playtex Products, Inc. |
Sunless tanning compositions
|
|
CN100500140C
(zh)
|
2000-05-09 |
2009-06-17 |
钟渊化学工业株式会社 |
含有作为活性成分的辅酶q的皮肤组合物
|
|
US6468552B1
(en)
|
2000-06-02 |
2002-10-22 |
Neutrogena Corporation |
Stabilized compositions containing oxygen-labile active agents
|
|
SE0002189D0
(sv)
*
|
2000-06-09 |
2000-06-09 |
Metcon Medicin Ab |
New method and assay
|
|
DE10031703A1
(de)
*
|
2000-06-29 |
2002-01-10 |
Beiersdorf Ag |
Verwendung von Calcium freisetzenden oder bindenden Substanzen zur gezielten Schächung oder Stärkung der Barrierefunktion der Haut
|
|
EP1170015A1
(de)
|
2000-07-06 |
2002-01-09 |
Laboratoires Serobiologiques(Societe Anonyme) |
Verwendung von Extrakten des Pilzes Grifola frondosa
|
|
DE10033022A1
(de)
*
|
2000-07-07 |
2002-01-17 |
Cognis Deutschland Gmbh |
Aerosole
|
|
US20030012825A1
(en)
|
2000-07-10 |
2003-01-16 |
Charles Kapper |
Metallized molecule therapies
|
|
US6465517B1
(en)
|
2000-07-11 |
2002-10-15 |
N.V. Nutricia |
Composition for the treatment of migraine
|
|
DE10034619A1
(de)
|
2000-07-17 |
2002-01-31 |
Cognis Deutschland Gmbh |
Aniontensidfreie niedrigviskose Trübungsmittel
|
|
DE10036655A1
(de)
|
2000-07-26 |
2002-02-07 |
Basf Ag |
Kosmetische oder dermatologische Zubereitungen zur Vermeidung von Hautschädigungen durch Peroxide
|
|
DE10036799A1
(de)
|
2000-07-28 |
2002-02-07 |
Beiersdorf Ag |
Neues Mittel zur Behandlung der Haare und der Kopfhaut
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US20020045230A1
(en)
|
2000-08-14 |
2002-04-18 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
FR2813195B1
(fr)
|
2000-08-29 |
2003-04-04 |
Serobiologiques Lab Sa |
Utilisation d'extraits de la plante cassia alata dans des produits de soin
|
|
US6441050B1
(en)
|
2000-08-29 |
2002-08-27 |
Raj K. Chopra |
Palatable oral coenzyme Q liquid
|
|
DE10048260A1
(de)
|
2000-09-29 |
2002-04-11 |
Beiersdorf Ag |
Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Aminoguanidin und/oder dessen Derivaten und Strukturanaloga zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
|
|
DE10053328A1
(de)
*
|
2000-10-27 |
2002-05-08 |
Cognis Deutschland Gmbh |
Kosmetische Zubereitungen
|
|
US6689385B2
(en)
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
|
US6403116B1
(en)
|
2000-11-03 |
2002-06-11 |
Triarco Inductries, Inc. |
Coenzyme Q10 formulation
|
|
IT1317938B1
(it)
|
2000-11-17 |
2003-07-15 |
Sigma Tau Healthscience Spa |
Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese
|
|
US20070003536A1
(en)
*
|
2000-11-21 |
2007-01-04 |
Zimmerman Amy C |
Topical skin compositions, their preparation, and their use
|
|
AUPR177300A0
(en)
|
2000-11-29 |
2000-12-21 |
Centre For Molecular Biology And Medicine |
Therapeutic methods
|
|
AU2002221934A1
(en)
|
2000-12-16 |
2002-06-24 |
Aventis Pharma Deutschland Gmbh |
Health promoting compositions
|
|
DE10064818A1
(de)
|
2000-12-22 |
2002-06-27 |
Basf Ag |
Verwendung von Chroman-Derivaten in kosmetischen oder dermatologischen Zubreitungen
|
|
US6806069B2
(en)
|
2001-01-09 |
2004-10-19 |
Pharmachem Laboratories, Inc. |
Ubiquinone composition and methods related thereto
|
|
FR2819414A1
(fr)
|
2001-01-15 |
2002-07-19 |
Cognis France Sa |
Preparations cosmetiques et/ou pharmaceutiques comprenant des extraits de plantes dites a resurrection
|
|
WO2002056823A2
(en)
|
2001-01-18 |
2002-07-25 |
Arnold Hoffman |
Redox therapy for tumors
|
|
KR20030071853A
(ko)
|
2001-01-25 |
2003-09-06 |
브리스톨-마이어스스퀴브컴파니 |
에포틸론 유사체를 함유한 비경구용 제제
|
|
NL1017205C2
(nl)
|
2001-01-26 |
2002-07-29 |
Adriaan Emanuel Hendricus Wiel |
Medicinale en cosmetische toepassing van hop en co-enzym Q10.
|
|
ITRM20010044A1
(it)
*
|
2001-01-29 |
2002-07-29 |
Sigma Tau Healthscience Spa |
Integratore alimentare ad effetto dimagrante.
|
|
IL157145A0
(en)
|
2001-01-31 |
2004-02-08 |
Idec Pharma Corp |
Use of dc23 antagonists for the treatment of neoplastic disorders
|
|
ITMI20010204A1
(it)
|
2001-02-02 |
2002-08-02 |
Hunza Di Marazzita Maria Carme |
Specialita' terapeutiche dotate di attivita' antiossidante ed in grado di controllare l'eccesso del peso corporeo
|
|
FR2821624B1
(fr)
|
2001-03-01 |
2004-01-02 |
Sod Conseils Rech Applic |
Nouveau polynucleotide utilisable pour moduler la proliferation des cellules cancereuses
|
|
MXPA03007802A
(es)
|
2001-03-09 |
2003-12-08 |
Nestle Sa |
Composicion que mejora las deficiencias fisiologicas relacionadas con la edad y que incrementa la longevidad.
|
|
DE10113053A1
(de)
|
2001-03-15 |
2002-09-19 |
Beiersdorf Ag |
Selbstschäumende oder schaumförmige Zubereitungen mit anorganischen Gelbildnern und organischen Hydrololloiden
|
|
DE10113050A1
(de)
|
2001-03-15 |
2002-09-19 |
Beiersdorf Ag |
Selbstschäumende oder schaumförmige Zubereitungen organischen Hydrokolloiden
|
|
DE10113046A1
(de)
|
2001-03-15 |
2002-09-26 |
Beiersdorf Ag |
Selbstschäumende schaumförmige Zubereitungen mit organischen Hydrokolliden und partikulären hydrophobisierten und/oder ölabsorbierenden Festkörpersubstanzen
|
|
ATE327006T1
(de)
|
2001-03-23 |
2006-06-15 |
Oreal |
Hautbehandlungsmittel enthaltend fasern und ubichinone
|
|
US20030031688A1
(en)
*
|
2001-04-02 |
2003-02-13 |
Dipak Ghosh |
Cosmetic composition with improved skin moisturizing properties
|
|
US6727234B2
(en)
|
2001-04-03 |
2004-04-27 |
University Of Iowa Research Foundation |
Isoprenoid analog compounds and methods of making and use thereof
|
|
US6469061B1
(en)
|
2001-04-04 |
2002-10-22 |
Ramot University Authority For Applied Research And Industrial Development Limited |
Jasmonate pharmaceutical composition for treatment of cancer
|
|
DE10118269A1
(de)
*
|
2001-04-12 |
2002-10-17 |
Cognis Deutschland Gmbh |
Kosmetische Zubereitungen
|
|
US6686485B2
(en)
*
|
2001-04-19 |
2004-02-03 |
Daniel David West |
Synthesis of coenzyme Q10, ubiquinone
|
|
US20040049022A1
(en)
|
2001-04-24 |
2004-03-11 |
Nyce Jonathan W. |
Composition & methods for treatment and screening
|
|
AU2002303427A1
(en)
|
2001-04-24 |
2002-11-05 |
East Carolina University |
Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
|
|
WO2002085308A2
(en)
|
2001-04-24 |
2002-10-31 |
Epigenesis Pharmaceuticals, Inc. |
Antisense and anti-inflammatory based compositions to treat respiratory disorders
|
|
US6582723B2
(en)
|
2001-05-03 |
2003-06-24 |
Wayne F. Gorsek |
Cancer immune composition for prevention and treatment of individuals
|
|
JP3742602B2
(ja)
|
2001-05-09 |
2006-02-08 |
株式会社カネカ |
還元型補酵素ｑの安定な溶液
|
|
GB0111279D0
(en)
|
2001-05-10 |
2001-06-27 |
Nycomed Imaging As |
Radiolabelled liposomes
|
|
KR100685696B1
(ko)
|
2001-05-10 |
2007-02-23 |
카네카 코포레이션 |
활성 성분으로 조효소 ｑ를 함유하는 경점막 투여용 조성물
|
|
JP4603192B2
(ja)
|
2001-05-10 |
2010-12-22 |
株式会社カネカ |
毛髪頭皮用組成物
|
|
DE10123771B4
(de)
|
2001-05-16 |
2019-01-10 |
Beiersdorf Ag |
Verwendung von Elektrolyten zur Stärkung der Barrierefunktion der Haut
|
|
EP1260212A1
(de)
|
2001-05-21 |
2002-11-27 |
Cognis France S.A. |
Kosmetische Mittel
|
|
US20050118151A1
(en)
*
|
2001-05-29 |
2005-06-02 |
Syddansk Universitet |
Proteins in diabetes proteome anlysis
|
|
MXPA03010888A
(es)
|
2001-05-30 |
2004-02-27 |
Laxdale Ltd |
Coenzimas q y acido eicosapentaenoico (epa).
|
|
US20030138792A1
(en)
|
2001-05-31 |
2003-07-24 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
|
|
US7091241B2
(en)
|
2001-06-01 |
2006-08-15 |
Summa Health System |
Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined vitamins C and K3
|
|
EP1262167A1
(de)
|
2001-06-01 |
2002-12-04 |
Cognis France S.A. |
Kosmetische Zubereitungen enthaltend ein Extrakt von keimenden Pflanzen
|
|
US6506915B1
(en)
|
2001-06-14 |
2003-01-14 |
Daniel David West |
Synthesis of coenzyme Q10 ubiquinone
|
|
US6696060B2
(en)
|
2001-06-14 |
2004-02-24 |
Clearant, Inc. |
Methods for sterilizing preparations of monoclonal immunoglobulins
|
|
FR2826017B1
(fr)
|
2001-06-15 |
2004-06-11 |
Cognis France Sa |
Melanges de tensioactifs
|
|
SE0102380D0
(sv)
|
2001-07-02 |
2001-07-02 |
Macronova Ab |
Kräm för behandling av åldersförändringar i huden hos människa
|
|
DE10133198A1
(de)
|
2001-07-07 |
2003-01-23 |
Beiersdorf Ag |
Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
|
|
JP2003020495A
(ja)
|
2001-07-10 |
2003-01-24 |
Cognis Japan Ltd |
油脂組成物
|
|
WO2003006478A1
(en)
|
2001-07-10 |
2003-01-23 |
Oligos Etc. Inc. |
Oligonucleotide-containing pharmacological compositions and their use
|
|
CH695085A5
(de)
|
2001-07-13 |
2005-12-15 |
Mibelle Ag Cosmetics |
Formulierungen zur Pflege der Haut nach Laserbehandlungen und/oder chemischen Peelings und Verwendung der Formulierungen.
|
|
TWI235146B
(en)
*
|
2001-07-16 |
2005-07-01 |
Kaneka Corp |
Method of stabilizing reduced coenzyme q10 and method of acidic crystallization
|
|
IL159894A0
(en)
|
2001-07-17 |
2004-06-20 |
Res Dev Foundation |
Therapeutic agents comprising pro-apoptotic proteins
|
|
FR2827603B1
(fr)
|
2001-07-18 |
2003-10-17 |
Oreal |
Composes derives de diaminopyrazole substitues par un radical heteroaromatique et leur utilisation en teinture d'oxydation des fibres keratiniques
|
|
EP1411951B2
(en)
|
2001-07-27 |
2010-11-10 |
N.V. Nutricia |
Enteral compositions for the prevention and/or treatment of sepsis
|
|
EP1281392A1
(de)
|
2001-08-02 |
2003-02-05 |
Cognis France S.A. |
Kosmetische und/oder pharmaceutische Zubereitungen enthaltend Pflanzenextrakte
|
|
DE10139580A1
(de)
*
|
2001-08-10 |
2003-02-20 |
Beiersdorf Ag |
Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen mit einem Gehalt an Sterinen und/oder C12-C40-Fettsäuren
|
|
US6503506B1
(en)
|
2001-08-10 |
2003-01-07 |
Millenium Biotechnologies, Inc. |
Nutrient therapy for immuno-compromised patients
|
|
DE10143963A1
(de)
|
2001-09-07 |
2003-03-27 |
Basf Ag |
Kosmetische und dermatologische Zubereitungen in Form von W/O-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon
|
|
DE10143962A1
(de)
|
2001-09-07 |
2003-03-27 |
Basf Ag |
Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon
|
|
DE10143964A1
(de)
|
2001-09-07 |
2003-03-27 |
Basf Ag |
Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
|
|
WO2003024417A1
(en)
|
2001-09-18 |
2003-03-27 |
Ciba Specialty Chemicals Holding Inc. |
Use of guaiol for treating the skin
|
|
DE10150725A1
(de)
*
|
2001-10-13 |
2003-04-17 |
Cognis Deutschland Gmbh |
Aniontensidfreie niedrigviskose Trübungsmittel
|
|
WO2003033662A2
(en)
|
2001-10-16 |
2003-04-24 |
Atherogenics, Inc. |
Protection against oxidative stress and inflammation by a cytoprotective response element
|
|
US7560123B2
(en)
|
2004-08-12 |
2009-07-14 |
Everett Laboratories, Inc. |
Compositions and methods for nutrition supplementation
|
|
WO2003037293A1
(de)
*
|
2001-10-26 |
2003-05-08 |
Cognis Deutschland Gmbh & Co. Kg |
Imprägnierlösung für kosmetiktücher
|
|
US6723527B2
(en)
|
2001-10-26 |
2004-04-20 |
Board Of Regents, The University Of Texas System |
Methods for determining toxicity reversing agents
|
|
BR0213842A
(pt)
|
2001-11-03 |
2004-08-31 |
Astrazeneca Ab |
Derivado de quinazolina ou um sal deste farmaceuticamente aceitável, processo para a preparação do mesmo, composição farmacêutica, e, uso do derivado de quinazolina ou de um sal deste farmaceuticamente aceitável
|
|
US20030105031A1
(en)
|
2001-11-06 |
2003-06-05 |
Rosenbloom Richard A. |
Methods for the treatment of skin disorders
|
|
US20030118536A1
(en)
|
2001-11-06 |
2003-06-26 |
Rosenbloom Richard A. |
Topical compositions and methods for treatment of adverse effects of ionizing radiation
|
|
US20030105027A1
(en)
|
2001-11-06 |
2003-06-05 |
Rosenbloom Richard A. |
Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
|
|
US7435725B2
(en)
|
2001-11-06 |
2008-10-14 |
The Quigly Corporation |
Oral compositions and methods for prevention, reduction and treatment of radiation injury
|
|
US6753325B2
(en)
|
2001-11-06 |
2004-06-22 |
The Quigley Corporation |
Composition and method for prevention, reduction and treatment of radiation dermatitis
|
|
CA2465900A1
(en)
*
|
2001-11-09 |
2003-05-15 |
Medstar Research Institute |
Method of using physiological markers to estimate cardiovascular risk
|
|
DE10155769A1
(de)
*
|
2001-11-14 |
2003-05-22 |
Cognis Deutschland Gmbh |
Kosmetische und/oder pharmazeutische Emulsionen
|
|
DE10160682A1
(de)
|
2001-12-11 |
2003-06-18 |
Cognis Deutschland Gmbh |
Emollients und kosmetische Zusammensetzungen
|
|
US6652891B2
(en)
|
2001-12-12 |
2003-11-25 |
Herbasway Laboratories, Llc |
Co-enzyme Q10 dietary supplement
|
|
DE10162026A1
(de)
|
2001-12-18 |
2003-07-03 |
Cognis Deutschland Gmbh |
Hochkonzentriert fließfähige Perlglanzkonzentrate
|
|
DE10162351A1
(de)
*
|
2001-12-18 |
2003-07-03 |
Cognis Deutschland Gmbh |
Kosmetische und/oder pharmazeutische Emulsionen
|
|
ITRM20010755A1
(it)
|
2001-12-20 |
2003-06-20 |
Simonelli Giuseppe |
Uso del chinone q10 per il trattamento delle malattie oculari.
|
|
TWI305547B
(en)
|
2001-12-27 |
2009-01-21 |
Kaneka Corp |
Processes for producing coenzyme q10
|
|
US20030129253A1
(en)
*
|
2002-01-03 |
2003-07-10 |
Milley Christopher J. |
Stable aqueous suspension
|
|
TW200302056A
(en)
|
2002-01-18 |
2003-08-01 |
Kaneka Corp |
Method for stabilizing reduced coenzyme Q10 and composition therefor
|
|
EP1469822A2
(de)
|
2002-01-18 |
2004-10-27 |
Basf Aktiengesellschaft |
Kosmetische oder dermatologische zubereitungen, enthaltend bor-organische verbindungen, zur vermei dung von hautschädigungen durch peroxide
|
|
WO2003063814A1
(en)
*
|
2002-01-31 |
2003-08-07 |
Ciba Specialty Chemicals Holding Inc. |
Micropigment mixtures
|
|
ATE334724T1
(de)
*
|
2002-02-12 |
2006-08-15 |
Dsm Ip Assets Bv |
Sonnenschutzzusammensetzungen sowie dihydropyridine und dihydropyrane
|
|
ES2302913T3
(es)
|
2002-02-14 |
2008-08-01 |
Dsm Ip Assets B.V. |
Formulaciones a base de coenzima q-10.
|
|
EP1340486A1
(de)
|
2002-03-01 |
2003-09-03 |
Cognis France S.A. |
Verwendung von Zuckerestern
|
|
US20030167556A1
(en)
|
2002-03-05 |
2003-09-11 |
Consumers Choice Systems, Inc. |
Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
|
|
DE10254315A1
(de)
|
2002-03-15 |
2003-10-02 |
Cognis Deutschland Gmbh |
Emollients und kosmetische Zubereitungen
|
|
EP1490399A2
(en)
|
2002-03-20 |
2004-12-29 |
Syddansk Universitet |
Human diabetes-mediating proteins
|
|
TW200304372A
(en)
|
2002-03-20 |
2003-10-01 |
Kanegafuchi Chemical Ind |
Compositions for diabetes
|
|
DE10212528A1
(de)
|
2002-03-21 |
2003-10-02 |
Cognis Deutschland Gmbh |
Ölphasen für kosmetische Mittel
|
|
DE10213957A1
(de)
*
|
2002-03-28 |
2003-10-09 |
Beiersdorf Ag |
Vernetzte kosmetische oder pharmazeutische phospholipidhaltige Gele und Emulsionen auf der Basis von ethylenoxidhaltigen oder propylenoxidhaltigen Emulgatoren
|
|
US7811594B2
(en)
|
2002-03-28 |
2010-10-12 |
Beiersdorf Ag |
Crosslinked oil droplet-based cosmetic or pharmaceutical emulsions
|
|
AU2003223520A1
(en)
*
|
2002-04-12 |
2003-10-27 |
Mitokor |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
|
DE10217474A1
(de)
|
2002-04-19 |
2003-11-06 |
Cognis Deutschland Gmbh |
Sonnenschutzemulsion mit Schaumspender
|
|
US20060193905A1
(en)
|
2002-05-14 |
2006-08-31 |
University Of Louisville Research Foundation, Inc. |
Direct cellular energy delivery system
|
|
WO2003099264A1
(en)
|
2002-05-23 |
2003-12-04 |
Umd, Inc. |
Compositions and method for transmucosal drug delivery and cryoprotection
|
|
DE10223486A1
(de)
*
|
2002-05-27 |
2003-12-11 |
Beiersdorf Ag |
Kosmetische und/oder dermatologische Zubereitung mit 2,3-Dibenzylbutyrolactonen
|
|
EP1371355B1
(en)
|
2002-06-03 |
2006-08-02 |
Ciba SC Holding AG |
UV-protection formulations
|
|
US7182950B2
(en)
|
2002-06-12 |
2007-02-27 |
Nutralease Ltd. |
Nano-sized self-assembled liquid dilutable vehicles
|
|
DE10226018A1
(de)
*
|
2002-06-12 |
2003-12-24 |
Cognis Deutschland Gmbh |
Zubereitungen mit konjugiertem Linolalkohol
|
|
US7147841B2
(en)
|
2002-06-17 |
2006-12-12 |
Ciba Specialty Chemicals Corporation |
Formulation of UV absorbers by incorporation in solid lipid nanoparticles
|
|
WO2004003564A2
(de)
|
2002-06-26 |
2004-01-08 |
Europroteome Ag |
Tumormarker und ihre verwendung zur diagnose und therapie von tumorerkrankungen
|
|
US7060733B2
(en)
|
2002-08-15 |
2006-06-13 |
The Regents Of The University Of California |
Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species
|
|
JP2006503852A
(ja)
|
2002-09-25 |
2006-02-02 |
ユニバーシティー オブ ロチェスター |
抗癌薬としてのカスパーゼインヒビター
|
|
US6953786B2
(en)
|
2002-10-01 |
2005-10-11 |
The Regents Of The University Of California |
Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
|
|
FR2845602B1
(fr)
*
|
2002-10-11 |
2005-07-08 |
Servier Lab |
Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
|
|
US7083813B2
(en)
|
2002-11-06 |
2006-08-01 |
The Quigley Corporation |
Methods for the treatment of peripheral neural and vascular ailments
|
|
EP1421929A3
(de)
|
2002-11-21 |
2004-11-24 |
Cognis Deutschland GmbH & Co. KG |
Emollients und kosmetische Zubereitungen
|
|
DE10256881A1
(de)
|
2002-12-05 |
2004-06-24 |
Beiersdorf Ag |
Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten
|
|
US20040110848A1
(en)
|
2002-12-10 |
2004-06-10 |
Peffley Dennis M |
Method and kit for treating cancer
|
|
JP2006509510A
(ja)
|
2002-12-16 |
2006-03-23 |
ガーバン インスティテュート オブ メディカル リサーチ |
摂食障害またはグルコース取込み障害の治療法と代謝修正およびそのための治療薬の同定のための方法
|
|
JP2006526140A
(ja)
|
2002-12-24 |
2006-11-16 |
バイオサイト インコーポレイテッド |
鑑別診断のためのマーカーおよびその使用方法
|
|
US8557512B2
(en)
*
|
2003-01-02 |
2013-10-15 |
HMI Medical Innovations, LLC |
Method of screening activators and/or inhibitors of insulin receptor substrate 2
|
|
US20090036516A1
(en)
|
2003-01-13 |
2009-02-05 |
Ctg Pharma S.R.L. |
Compounds for treating metabolic syndrome
|
|
CN1738592A
(zh)
|
2003-01-20 |
2006-02-22 |
西巴特殊化学品控股有限公司 |
作为uv吸收剂的三嗪衍生物
|
|
JP2006514661A
(ja)
|
2003-02-03 |
2006-05-11 |
デーエスエム アイピー アセッツ ベー． ヴェー． |
新規な安定化されたケイ皮酸エステルサンスクリーン組成物
|
|
US7258876B2
(en)
|
2003-02-05 |
2007-08-21 |
Craig Bozzacco |
Topical composition for treating infectious conditions of skin and mucosa
|
|
CN1208052C
(zh)
|
2003-03-20 |
2005-06-29 |
上海家化联合股份有限公司 |
一种辅酶q10前体脂质体及其制备方法
|
|
JP4764817B2
(ja)
|
2003-03-24 |
2011-09-07 |
チバ ホールディング インコーポレーテッド |
対称性トリアジン誘導体
|
|
CA2847543C
(en)
|
2003-04-08 |
2018-05-15 |
Barrie Tan |
Annatto extract compositions, including geranyl geraniols and methods of use
|
|
US20050037102A1
(en)
|
2003-07-18 |
2005-02-17 |
Barrie Tan |
Annatto extract compositions including tocotrienols and tocopherols and methods of use
|
|
JP2004321171A
(ja)
|
2003-04-11 |
2004-11-18 |
Fancl Corp |
飲食品
|
|
EP1473043A1
(en)
|
2003-04-29 |
2004-11-03 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Pharmaceutical combination for the treatment of diseases involving cell proliferation, migration or apotosis of myeloma cells, or angiogenesis
|
|
JP2004345988A
(ja)
|
2003-05-21 |
2004-12-09 |
Eisai Co Ltd |
リボフラビン系化合物を含む医薬組成物
|
|
US7438903B2
(en)
*
|
2003-06-06 |
2008-10-21 |
Nbty, Inc. |
Methods and compositions that enhance bioavailability of coenzyme-Q10
|
|
US20040253323A1
(en)
|
2003-06-11 |
2004-12-16 |
Giles Brian C. |
Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
|
|
US8003094B2
(en)
|
2003-06-25 |
2011-08-23 |
Charles Erwin |
Chemical combination and method for increasing delivery of Coenzyme Q10
|
|
US20050026879A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026848A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20070248693A1
(en)
|
2003-08-02 |
2007-10-25 |
Elizabeth Mazzio |
Nutraceutical composition and method of use for treatment / prevention of cancer
|
|
US8802161B2
(en)
|
2003-08-02 |
2014-08-12 |
Florida Agricultural And Mechanical University |
Herbal composition and method of use for the treatment of cancer
|
|
US20060035981A1
(en)
*
|
2003-08-02 |
2006-02-16 |
Mazzio Elizabeth A |
Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment
|
|
US20080069779A1
(en)
|
2003-08-04 |
2008-03-20 |
Foamix Ltd. |
Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
|
|
US20050036976A1
(en)
*
|
2003-08-12 |
2005-02-17 |
Joel Rubin |
Topical skin care composition
|
|
US8741321B2
(en)
*
|
2003-08-27 |
2014-06-03 |
Beiersdorf Ag |
Capsule whose envelope is separately imperceptible during the topical use thereof
|
|
US8124072B2
(en)
|
2003-09-29 |
2012-02-28 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
|
AU2004277951B2
(en)
|
2003-09-29 |
2010-11-11 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
|
US7169385B2
(en)
|
2003-09-29 |
2007-01-30 |
Ronald G. Udell |
Solubilized CoQ-10 and carnitine
|
|
EP1670434A4
(en)
|
2003-10-02 |
2010-06-23 |
Sembiosys Genetics Inc |
PROCESSES FOR PREPARING OILY BODIES COMPRISING ACTIVE INGREDIENTS
|
|
DE10347218A1
(de)
|
2003-10-10 |
2005-05-12 |
Cognis Deutschland Gmbh |
Sonnenschutzmittel
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
DE10347940A1
(de)
|
2003-10-15 |
2005-05-19 |
Cognis Deutschland Gmbh & Co. Kg |
Selbstemulgierende Zubereitungen
|
|
CN1870982B
(zh)
|
2003-10-31 |
2010-05-26 |
株式会社钟化 |
含还原型辅酶q的组合物
|
|
ATE450247T1
(de)
|
2003-11-05 |
2009-12-15 |
Dsm Ip Assets Bv |
Lichtschutzzusammensetzung mit verringerter gesamtmenge an uv-filter mit einem uv-filter auf polysiloxan-basis
|
|
US20050100537A1
(en)
|
2003-11-10 |
2005-05-12 |
Evans Gregory S. |
Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
|
|
US8932649B2
(en)
|
2003-11-14 |
2015-01-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds
|
|
DE10354052A1
(de)
|
2003-11-17 |
2005-06-16 |
Beiersdorf Ag |
Kosmetikum mit empfindlichen Inhaltsstoffen
|
|
US20050118235A1
(en)
|
2003-12-02 |
2005-06-02 |
Shiguang Yu |
Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake
|
|
PT1750651T
(pt)
|
2003-12-18 |
2018-02-16 |
Nestec Sa |
Composição para melhorar a saúde da pele, cabelo e pelo contendo flavanonas
|
|
JP4742526B2
(ja)
*
|
2003-12-26 |
2011-08-10 |
シンフォニアテクノロジー株式会社 |
Ｉｃチップ実装体の製造方法及び製造装置
|
|
EP1718283B1
(en)
|
2004-01-22 |
2013-03-06 |
University of Miami |
Topical co-enzyme q10 formulations and methods of use
|
|
US20050226947A1
(en)
*
|
2004-02-04 |
2005-10-13 |
Dale Kern |
Agents for sequestering serum aging factors and uses therefore
|
|
US20070149618A1
(en)
|
2004-02-17 |
2007-06-28 |
Action Medicines, S.L. |
Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
|
|
JP2007523156A
(ja)
*
|
2004-02-19 |
2007-08-16 |
ケマファー インコーポレイティッド |
皮膚状態の処置用の局所製剤
|
|
US7780873B2
(en)
|
2004-02-23 |
2010-08-24 |
Texas A&M University System |
Bioactive complexes compositions and methods of use thereof
|
|
EP1718163A1
(en)
|
2004-02-23 |
2006-11-08 |
The Texas A&M University System |
Antioxidant compositions and methods of use thereof
|
|
US20050202521A1
(en)
|
2004-03-10 |
2005-09-15 |
Albert Crum |
Methods of assessing the need for and the effectiveness of therapy with antioxidants
|
|
DE102004014615A1
(de)
|
2004-03-23 |
2005-10-13 |
Beiersdorf Ag |
Taurinhaltige Zubereitungen zur Verbesserung der Hautbarriere
|
|
BRPI0509712A
(pt)
*
|
2004-04-06 |
2007-09-18 |
Basf Ag |
método de proteger a pele humana ou o cabelo humano da radiação ultravioleta, formulação para cuidados pessoais contendo protetor solar para proteger a pele humana ou cabelo humano da radiação ultravioleta, e, partìcula tratada na superfìcie
|
|
US20050226858A1
(en)
|
2004-04-09 |
2005-10-13 |
Kaneka Corporation |
Compositions containing reduced coenzyme Q10 and carotenoid
|
|
US7723569B2
(en)
*
|
2004-04-30 |
2010-05-25 |
National Institute Of Agrobiological Sciences |
Method for producing ubiquinone-10 in plant
|
|
US7351739B2
(en)
|
2004-04-30 |
2008-04-01 |
Wellgen, Inc. |
Bioactive compounds and methods of uses thereof
|
|
IL161899A0
(en)
|
2004-05-10 |
2005-11-20 |
Hoffman Arnold |
Kit for treatment of cancer
|
|
JP2005323573A
(ja)
|
2004-05-17 |
2005-11-24 |
Sumitomo Pharmaceut Co Ltd |
遺伝子発現データ解析方法および、疾患マーカー遺伝子の選抜法とその利用
|
|
RU2375053C2
(ru)
|
2004-05-18 |
2009-12-10 |
Кемийски Инштитут |
Новая водорастворимая форма коэнзима q10 в форме комплекса включения с бета-циклодекстрином, способ ее получения и ее применение
|
|
EP1763334B1
(de)
|
2004-05-24 |
2008-12-17 |
Basf Se |
Keratin-bindende polypeptide
|
|
KR20050112942A
(ko)
|
2004-05-28 |
2005-12-01 |
주식회사 뉴트렉스테크놀러지 |
비만 억제용 조성물
|
|
US20050288333A1
(en)
|
2004-06-08 |
2005-12-29 |
Kem William R |
Controlling angiogenesis with anabaseine analogs
|
|
US7906140B2
(en)
|
2004-06-17 |
2011-03-15 |
Virun, Inc. |
Compositions for mucosal delivery of agents
|
|
WO2005123101A1
(en)
*
|
2004-06-18 |
2005-12-29 |
Symrise Gmbh & Co. Kg |
Blackberry extract
|
|
EP1784172A4
(en)
*
|
2004-06-21 |
2007-12-19 |
Hutchison Medipharma Entpr Ltd |
CANCER CHEMOTHERAPY
|
|
KR101371911B1
(ko)
|
2004-06-28 |
2014-03-10 |
디에스엠 아이피 어셋츠 비.브이. |
단백질 가수분해산물을 함유하는 화장품 조성물
|
|
US20070225255A1
(en)
|
2004-07-13 |
2007-09-27 |
Eleonore Frohlich |
Use of Mitochondrially Targeted Antioxidant in the Treatment of Liver Diseases and Epithelial Cancers
|
|
US20060069068A1
(en)
|
2004-07-15 |
2006-03-30 |
Nanobac Pharmaceuticals, Inc. |
Methods and compositions for the treatment of diseases characterized by pathological calcification
|
|
JP2008508301A
(ja)
|
2004-07-28 |
2008-03-21 |
エム． プレヴァ，レイモンド |
エミュー油と果実の組成物
|
|
JP2006070016A
(ja)
|
2004-08-02 |
2006-03-16 |
Kaneka Corp |
還元型補酵素ｑを含有する美白用組成物
|
|
WO2006017494A2
(en)
*
|
2004-08-02 |
2006-02-16 |
Elizabeth Mazzio |
Inhibition of anaerobic glucose metabolism
|
|
ZA200702216B
(en)
|
2004-08-18 |
2008-11-26 |
Ace Aps |
Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
|
|
US20060041017A1
(en)
|
2004-08-20 |
2006-02-23 |
Chopra Raj K |
Synergistic conjugated linoleic acid (CLA) and carnitine combination
|
|
US20060051462A1
(en)
*
|
2004-09-03 |
2006-03-09 |
Wang Jimmy X |
Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
|
|
US7288263B2
(en)
*
|
2004-09-13 |
2007-10-30 |
Evera Laboratories, Llc |
Compositions and methods for treatment of skin discoloration
|
|
ZA200703087B
(en)
|
2004-09-17 |
2009-04-29 |
Inst Of Medicinal Biotechno |
Methods and compositions for the treatment of hyperlipidemia
|
|
US20060062755A1
(en)
|
2004-09-21 |
2006-03-23 |
Woodward John R |
Method of cancer screening; method of cancer treatment; and method of diabetes treatment
|
|
DE102004046235A1
(de)
|
2004-09-22 |
2006-03-30 |
Altana Pharma Ag |
Arzneimittelzubereitung
|
|
JP5093998B2
(ja)
|
2004-09-22 |
2012-12-12 |
大塚製薬株式会社 |
色素沈着予防又は改善剤
|
|
DE602005010899D1
(de)
|
2004-09-27 |
2008-12-18 |
Sigmoid Pharma Ltd |
Mikrokapseln mit einem methylxanthin und einem kortikosteroid
|
|
US20060121016A1
(en)
|
2004-10-18 |
2006-06-08 |
Lee Raphael C |
Methods and compositions for treatment of free radical injury
|
|
WO2006050155A2
(en)
|
2004-10-29 |
2006-05-11 |
Biomune, Inc. |
Cancer therapeutic compositions
|
|
BRPI0517930A
(pt)
*
|
2004-11-02 |
2008-10-21 |
Dsm Ip Assets Bv |
aditivo para preparações de protetor solar contra uv
|
|
US8349359B2
(en)
|
2004-11-07 |
2013-01-08 |
Your Energy Systems, LLC |
Liposomal formulation for oral administration of glutathione (reduced)
|
|
GB0424891D0
(en)
|
2004-11-11 |
2004-12-15 |
Boots Co Plc |
Topical compositions
|
|
EP1811977B1
(en)
*
|
2004-11-16 |
2018-01-10 |
Bioavailability, Inc. |
High concentration self-microemulsifying coenzyme q10 preparations for nutritional use
|
|
US20060110415A1
(en)
|
2004-11-22 |
2006-05-25 |
Bioderm Research |
Topical Delivery System for Cosmetic and Pharmaceutical Agents
|
|
US20060127384A1
(en)
|
2004-12-09 |
2006-06-15 |
Sergio Capaccioli |
Coenzyme Q10 as antiapoptotic agent
|
|
US7862995B2
(en)
|
2004-12-10 |
2011-01-04 |
Targeted Molecular Diagnostics |
Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
|
|
WO2006063733A1
(en)
*
|
2004-12-14 |
2006-06-22 |
F.Hoffmann-La Roche Ag |
Cd99 as target/marker for insulin resistance
|
|
WO2006063402A1
(en)
|
2004-12-16 |
2006-06-22 |
Melvin Mackenzie Stewart |
Therapeutic compositions based on extracts of plants from the genus plumeria (frangipani)
|
|
NO20045674D0
(no)
|
2004-12-28 |
2004-12-28 |
Uni I Oslo |
Thin films prepared with gas phase deposition technique
|
|
US20060286046A1
(en)
|
2005-01-05 |
2006-12-21 |
Haber C Andrew |
Skin care compositions
|
|
US20060188492A1
(en)
|
2005-01-13 |
2006-08-24 |
Chronorx Llc, An Alaska Limited Liability Company |
Topical management of ocular and periocular conditions
|
|
DE102005007980A1
(de)
|
2005-02-22 |
2006-02-23 |
Clariant Gmbh |
Kosmetische, pharmazeutische oder dermatologische Zubereitungen enthaltend Copolymerwachse
|
|
JPWO2006103750A1
(ja)
|
2005-03-29 |
2008-09-04 |
日本ハム株式会社 |
肥満改善用組成物、機能性食品及び医薬用組成物
|
|
EP1871389A2
(en)
|
2005-04-01 |
2008-01-02 |
Zymes, LLC |
Skin enrichment using coq10 as the delivery system
|
|
CN1853507A
(zh)
|
2005-04-28 |
2006-11-01 |
尚宝虎 |
一种没有副作用的可用于饮料和固体口服制剂或食品添加的减肥新组方
|
|
JP2007001922A
(ja)
|
2005-06-23 |
2007-01-11 |
Asahi Kasei Pharma Kk |
透析患者における腎疾患改善剤、又は機能性食品
|
|
EP1908459A4
(en)
*
|
2005-07-28 |
2010-07-14 |
Kaneka Corp |
COMPOSITION FOR THE PREVENTION OF CANCER
|
|
EP1909763A2
(en)
|
2005-07-28 |
2008-04-16 |
Isp Investments Inc. |
Benzoquinones of enhanced bioavailability
|
|
US20070053985A1
(en)
*
|
2005-08-24 |
2007-03-08 |
Kaneka Corporation |
Coenzyme Q10-containing fine particle with excellent dispersibility
|
|
CN1928556A
(zh)
*
|
2005-09-05 |
2007-03-14 |
中国医学科学院基础医学研究所 |
中国人2型糖尿病血清标志物的检测试剂盒
|
|
US20070071779A1
(en)
|
2005-09-26 |
2007-03-29 |
Leggit Ingenuity, Llc |
Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
|
|
EP1876448A1
(en)
|
2005-09-30 |
2008-01-09 |
DIGILAB BioVisioN GmbH |
Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones.
|
|
US20070092469A1
(en)
*
|
2005-10-26 |
2007-04-26 |
Eric Jacobs |
Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
|
|
US8506956B2
(en)
*
|
2005-10-31 |
2013-08-13 |
Kaneka Corporation |
Method for stabilizing reduced coenzyme Q10
|
|
US9265792B2
(en)
*
|
2005-11-16 |
2016-02-23 |
Patricia A. Riley |
Integument cell regeneration formulation
|
|
EP1960551A2
(en)
|
2005-12-01 |
2008-08-27 |
Medical Prognosis Institute |
Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
US20070248590A1
(en)
|
2005-12-02 |
2007-10-25 |
Sirtris Pharmaceuticals, Inc. |
Modulators of CDC2-like kinases (CLKS) and methods of use thereof
|
|
JP2007176804A
(ja)
*
|
2005-12-27 |
2007-07-12 |
Ｚｍｃ−Ｋｏｕｇｅｎ株式会社 |
痩身作用を有する医薬又は健康食品
|
|
US20070172436A1
(en)
|
2006-01-23 |
2007-07-26 |
Jerry Zhang |
Nonaqueous ascorbic acid compositions and methods for preparing same
|
|
US20070184076A1
(en)
|
2006-02-07 |
2007-08-09 |
Unger Evan C |
Liquid-filled nanodroplets for anti-cancer therapy
|
|
US20070184041A1
(en)
|
2006-02-09 |
2007-08-09 |
Burja Adam M |
Methods and compositions related to production of coenzyme q10
|
|
WO2007095186A2
(en)
*
|
2006-02-14 |
2007-08-23 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
|
|
US8067152B2
(en)
|
2006-02-27 |
2011-11-29 |
The Fred Hutchinson Cancer Research Center |
Liver cancer biomarkers
|
|
US20070203091A1
(en)
|
2006-02-28 |
2007-08-30 |
Eliezer Rapaport |
Methods and therapeutic compositions for improving liver, blood flow and skeletal muscle functions in advanced diseases and aging
|
|
DE502007001190D1
(de)
|
2006-03-10 |
2009-09-10 |
Laboswiss Ag |
Verfahren zum solubilisieren, dispergieren und stabilisieren von stoffen, nach dem verfahren hergestellte erzeugnisse sowie die verwendung derselben
|
|
US7335384B2
(en)
|
2006-03-17 |
2008-02-26 |
4K Nutripharma International |
Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
|
|
US8030013B2
(en)
*
|
2006-04-14 |
2011-10-04 |
Mount Sinai School Of Medicine |
Methods and compositions for the diagnosis for early hepatocellular carcinoma
|
|
WO2007126086A1
(ja)
|
2006-04-28 |
2007-11-08 |
Kaneka Corporation |
還元型補酵素ｑ10の精製方法
|
|
US8021659B2
(en)
|
2006-04-28 |
2011-09-20 |
Naidu Lp |
Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
|
|
WO2007126083A1
(ja)
|
2006-04-28 |
2007-11-08 |
Kaneka Corporation |
還元型補酵素ｑ10の安定化方法
|
|
CA2650825C
(en)
|
2006-05-02 |
2015-07-14 |
University Of Miami |
Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
|
|
EP2180320A1
(en)
|
2006-06-05 |
2010-04-28 |
Shimadzu Corporation |
Tumor marker and method for determination of the occurence of cancerous disease
|
|
US20080020022A1
(en)
*
|
2006-06-05 |
2008-01-24 |
Udell Ronald G |
Chewable co-enzyme q-10 capsule
|
|
US20080014187A1
(en)
*
|
2006-07-15 |
2008-01-17 |
Bryant Villeponteau |
Compositions and Methods for Treating Hypertension and Inflammation
|
|
US8894993B2
(en)
|
2006-08-04 |
2014-11-25 |
Natreon Inc. |
Mitochondria-targeted antioxidants
|
|
CA2662517A1
(en)
|
2006-09-05 |
2008-03-13 |
Jerome Moore |
Treatment of cancer
|
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
|
EP2123266B1
(en)
|
2006-12-06 |
2014-01-15 |
Kaneka Corporation |
Cancer therapeutic agent and anti-carcinogenic agent
|
|
CN101015524B
(zh)
*
|
2007-02-15 |
2011-09-14 |
沈阳药科大学 |
辅酶q10口服乳剂及其制备方法
|
|
US8454945B2
(en)
|
2007-03-22 |
2013-06-04 |
Berg Pharma Llc |
Topical formulations having enhanced bioavailability
|
|
WO2008156654A2
(en)
|
2007-06-15 |
2008-12-24 |
Massachusetts Institute Of Technology |
Cytoskeleton modulators for treating metabolic disorders
|
|
US20090005398A1
(en)
|
2007-06-27 |
2009-01-01 |
Mohammed Dar |
Methods For The Treatment of Central Nervous System Tumors
|
|
US7989007B2
(en)
|
2007-07-03 |
2011-08-02 |
Vincent James Enterprises, Llc |
Weight loss composition
|
|
KR100849537B1
(ko)
|
2007-07-04 |
2008-07-31 |
유효경 |
코엔자임 큐텐의 나노에멀젼 조성물
|
|
WO2009014639A2
(en)
|
2007-07-17 |
2009-01-29 |
Metabolon, Inc. |
Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
|
|
CN101091890A
(zh)
|
2007-07-26 |
2007-12-26 |
沈阳药科大学 |
一种复合型乳化剂及用其制备的乳剂及其制备方法
|
|
US7776894B2
(en)
|
2007-08-17 |
2010-08-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting growth and metastasis of melanoma
|
|
RU2345367C1
(ru)
|
2007-08-22 |
2009-01-27 |
Государственное образовательное учреждение высшего профессионального образования Новосибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию (ГОУ ВПО НГМУ Росздрава) |
Способ прогнозирования тяжести течения и эффективности лечения лимфом
|
|
JP2009050168A
(ja)
|
2007-08-23 |
2009-03-12 |
Tsujido Kagaku Kk |
食品組成物
|
|
EP2197917A1
(en)
|
2007-09-28 |
2010-06-23 |
Universitätsspital Basel |
Immunoliposomes for treatment of cancer
|
|
JP2009096757A
(ja)
*
|
2007-10-17 |
2009-05-07 |
Tsujido Kagaku Kk |
脂肪代謝抑制剤
|
|
WO2009073843A1
(en)
*
|
2007-12-06 |
2009-06-11 |
Cytotech Labs, Llc |
Inhalable compositions having enhanced bioavailability
|
|
WO2009126764A1
(en)
*
|
2008-04-11 |
2009-10-15 |
Cytotech Labs, Llc |
Methods and use of inducing apoptosis in cancer cells
|
|
JP5945096B2
(ja)
|
2008-07-04 |
2016-07-05 |
小野薬品工業株式会社 |
抗ヒトｐｄ−１抗体の癌に対する治療効果を最適化するための判定マーカーの使用
|
|
WO2010065601A1
(en)
|
2008-12-03 |
2010-06-10 |
Amorcyte, Inc. |
Infarct area perfusion-improving compositions and methods of vascular injury repair
|
|
DE102008060773A1
(de)
|
2008-12-05 |
2010-06-10 |
Sartorius Stedim Biotech Gmbh |
Verschluss für einen Behälter
|
|
US8247435B2
(en)
|
2009-02-19 |
2012-08-21 |
Thornthwaite Jerry T |
Formulations for treating human and animal diseases
|
|
CN102482713B
(zh)
|
2009-05-11 |
2017-06-30 |
博格有限责任公司 |
利用表观代谢转变剂、多维细胞内分子或环境影响剂诊断肿瘤障碍的方法
|
|
CN102548549A
(zh)
|
2009-08-25 |
2012-07-04 |
细胞研究有限公司 |
利用外代谢转换剂(辅酶q10)治疗肉瘤的方法
|
|
US8506954B2
(en)
|
2009-12-01 |
2013-08-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
|
|
ES2664793T3
(es)
|
2010-03-12 |
2018-04-23 |
Berg Llc |
Formulaciones intravenosas de coenzima Q10 (CoQ10) y métodos de uso de las mismas
|
|
KR20190031592A
(ko)
|
2010-07-19 |
2019-03-26 |
바이오젠 체사피크 엘엘씨 |
글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
|
|
US9125835B2
(en)
|
2010-11-12 |
2015-09-08 |
Rutgers, The State University Of New Jersey |
Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases
|
|
AU2012236479B2
(en)
|
2011-03-31 |
2016-10-20 |
Merck Sharp & Dohme Llc |
Stable formulations of antibodies to human programmed death receptor PD-1 and related treatments
|
|
WO2012138765A1
(en)
|
2011-04-04 |
2012-10-11 |
Berg Pharma Llc |
Methods of treating central nervous system tumors
|
|
EP2835047B1
(en)
|
2012-04-03 |
2017-09-20 |
Quizcamp-Fabrico e Comércio Produtos Alimentares, S.A. |
Modular integrated system for seed germination, cultivation, planting, fertilizing and maintenance of plants
|
|
US20140017317A1
(en)
|
2012-06-01 |
2014-01-16 |
Niven Rajin Narain |
Methods of treatment of solid tumors using coenzyme q10
|
|
EA032775B1
(ru)
|
2013-04-08 |
2019-07-31 |
Берг Ллк |
Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
|
|
EP3041496B1
(en)
|
2013-09-04 |
2020-04-29 |
Berg LLC |
Methods of treatment of cancer by continuous infusion of coenzyme q10
|
|
JP6398212B2
(ja)
|
2014-02-12 |
2018-10-03 |
株式会社Ihi |
軸受構造、および、過給機
|
|
JP2017530130A
(ja)
|
2014-10-03 |
2017-10-12 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
腫瘍が誘発する自然免疫応答の免疫抑制を阻害する方法としてのアネキシンｖの使用
|
|
AU2015335029B2
(en)
|
2014-10-24 |
2021-09-23 |
Astrazeneca Ab |
Combination
|
|
US9827308B2
(en)
|
2014-12-10 |
2017-11-28 |
Wisconsin Alumni Research Foundation |
Mini-intronic plasmid DNA vaccines in combination with LAG3 blockade
|
|
US20170189350A1
(en)
|
2015-11-16 |
2017-07-06 |
Berg Llc |
Methods of treatment of temozolomide-resistant glioma using coenzyme q10
|
|
WO2018018018A1
(en)
|
2016-07-21 |
2018-01-25 |
Berg Llc |
Methods for the treatment of cancer using coenzyme q10 in combination with immune checkpoint modulators
|
|
US10373477B1
(en)
|
2016-09-28 |
2019-08-06 |
Gojo Industries, Inc. |
Hygiene compliance modules for dispensers, dispensers and compliance monitoring systems
|
|
JP6895250B2
(ja)
|
2016-12-28 |
2021-06-30 |
日東電工株式会社 |
表面保護フィルム
|
|
CN116159242A
(zh)
|
2018-07-03 |
2023-05-26 |
埃德温·阊 |
使用交变电场提高细胞膜通透性
|
|
US20200138744A1
(en)
|
2018-10-15 |
2020-05-07 |
Berg Llc |
Methods of treating pancreatic cancer using coenzyme q10
|
|
US20210322339A1
(en)
|
2019-11-20 |
2021-10-21 |
Berg Llc |
Combination therapy of coenzyme q10 and radiation for treatment of glioma
|